The Bolivian Society of Infectology publishes the epidemiological file of monkeypox

The Bolivian Society of Infectious Diseases (Sobodi) announced the epidemiological record of the so-called monkeypox. In its health alert on May 20, the World Health Organization (WHO) announced that monkeypox is found in 11 countries.

The objective of this epidemiological file, according to the Sobodi document, is to “quickly identify the sick and the sources of infection to provide proper medical care, isolate patients to prevent transmissionidentify and follow up on contacts (…) and adopt control and prevention measures based on the routes of transmission”.

For this organization, A case suspect is a person with an acute skin rash, whose cause is not identified; It also indicates as symptoms: headache, fever greater than 38.5 °C, swollen glands in the neck area, muscle pain and severe fatigue.

It also emphasizes that other diseases such as chicken pox, measles, herpes simplex or bacterial skin infections, among other ailments that include skin rashes.

On the other hand, Sobodi defines as likely case, that of a person who, in addition to meeting the definition of a suspected case, would have had physical contact with skin lesions, sexual contact with a person probable or suspected monkeypox, 21 days before onset of symptoms. Also if you traveled in a country where this disease exists, or if you have several sexual partners.

It can also be a probable case if the serologic test for orthopoxvirus is positive without having been vaccinated against smallpox.

Finally, the Bolivian Society of Infectious Diseases defines as confirmed case of monkeypox to a person who meets the definitions of suspected or probable case and who, in addition, had carried out a positive real-time PCR test for monkeypox.

Prevention

Regarding prevention, Juan Saavedra, president of Sobodi, pointed out that until pharmaceutical companies develop a specific vaccine against this disease, perhaps the smallpox vaccine will be used.

Smallpox that affects man it was eradicated in 1978 and, since 1980, smallpox vaccination has no longer been vaccinated in the world”, explained the specialist who also mentioned that those who had received this vaccine (until 1978) will have immunity to some degree.

He also mentioned that in Europe there is a medicine called Tecovirimat, which is specific for the treatment of monkeypox. They are tablets that are administered for 14 days and have been used since 2019.

On the other hand, he indicated that if there is someone with the aforementioned symptoms and who is also returning from countries where cases have already occurred, or had contact with a suspected case, should be kept in isolation until confirmed or ruled out, with a PCR test with monkeypox reagents.

differences

The infectologist explained that chickenpox and smallpox are not the same disease. In the case of the first, he pointed out that the different lesions that appear on the skin (eruptions, spots, papules, vesicles and pustules) occur at different times, so they can coexist simultaneously. Whereas, in smallpox the lesions evolve together. Also, in the vmonkey prairie glands in the neck area swell.

smallpox vaccine

The smallpox vaccine can protect people from monkeypox in a high percentage, but this has already ceased to be applied in Bolivia since the 1980s. In other words, this vaccine is not part of the Expanded Vaccination Program guaranteed by the State. According to Saavedra, only Bolivians over 50 years of age have received the vaccine as children.

For his part, Dr. Jorge QuirozCoordinator of Urban Health Networks of the Government, said that ethere are laboratories that They will bring the vaccine in a private way and that it can be applied at any private immunization bank.

The Bolivian Society of Infectious Diseases (Sobodi) announced the epidemiological record of the so-called monkeypox. In its health alert on May 20, the World Health Organization (WHO) announced that monkeypox is found in 11 countries.

The objective of this epidemiological file, according to the Sobodi document, is to “quickly identify the sick and the sources of infection to provide proper medical care, isolate patients to prevent transmissionidentify and follow up on contacts (…) and adopt control and prevention measures based on the routes of transmission”.

For this organization, A case suspect is a person with an acute skin rash, whose cause is not identified; It also indicates as symptoms: headache, fever greater than 38.5 °C, swollen glands in the neck area, muscle pain and severe fatigue.

It also emphasizes that other diseases such as chicken pox, measles, herpes simplex or bacterial skin infections, among other ailments that include skin rashes.

On the other hand, Sobodi defines as likely case, that of a person who, in addition to meeting the definition of a suspected case, would have had physical contact with skin lesions, sexual contact with a person probable or suspected monkeypox, 21 days before onset of symptoms. Also if you traveled in a country where this disease exists, or if you have several sexual partners.

It can also be a probable case if the serologic test for orthopoxvirus is positive without having been vaccinated against smallpox.

Finally, the Bolivian Society of Infectious Diseases defines as confirmed case of monkeypox to a person who meets the definitions of suspected or probable case and who, in addition, had carried out a positive real-time PCR test for monkeypox.

Prevention

Regarding prevention, Juan Saavedra, president of Sobodi, pointed out that until pharmaceutical companies develop a specific vaccine against this disease, perhaps the smallpox vaccine will be used.

Smallpox that affects man it was eradicated in 1978 and, since 1980, smallpox vaccination has no longer been vaccinated in the world”, explained the specialist who also mentioned that those who had received this vaccine (until 1978) will have immunity to some degree.

He also mentioned that in Europe there is a medicine called Tecovirimat, which is specific for the treatment of monkeypox. They are tablets that are administered for 14 days and have been used since 2019.

On the other hand, he indicated that if there is someone with the aforementioned symptoms and who is also returning from countries where cases have already occurred, or had contact with a suspected case, should be kept in isolation until confirmed or ruled out, with a PCR test with monkeypox reagents.

differences

The infectologist explained that chickenpox and smallpox are not the same disease. In the case of the first, he pointed out that the different lesions that appear on the skin (eruptions, spots, papules, vesicles and pustules) occur at different times, so they can coexist simultaneously. Whereas, in smallpox the lesions evolve together. Also, in the vmonkey prairie glands in the neck area swell.

smallpox vaccine

The smallpox vaccine can protect people from monkeypox in a high percentage, but this has already ceased to be applied in Bolivia since the 1980s. In other words, this vaccine is not part of the Expanded Vaccination Program guaranteed by the State. According to Saavedra, only Bolivians over 50 years of age have received the vaccine as children.

For his part, Dr. Jorge QuirozCoordinator of Urban Health Networks of the Government, said that ethere are laboratories that They will bring the vaccine in a private way and that it can be applied at any private immunization bank.

;

The post The Bolivian Society of Infectology publishes the epidemiological file of monkeypox appeared first on World Today News.

Source link

Leave a Comment